Drug Trial Radar · NCT02888106
Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent
Last checked: Nov 20, 2026Latest source record: Apr 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
90
Actual
Start
Apr 2016
Primary completion
Nov 22, 2019
Study completion Oct 30, 2020
Sponsor
- Lead sponsor
- Hepatera Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 2, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Randomised, Comparative, Parallel-Arm Study to Assess Efficacy and Safety of Myrcludex B in Combination with Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients with Chronic Viral Hepatitis B with Delta-agent
Conditions
- Chronic Viral Hepatitis B With Delta-agent
Interventions
Myrcludex BDrug
Lyophilised powder for solution for subcutaneous injection
PEG IFN alfa-2aDrug
solution for subcutaneous injection, once per week
TenofovirDrug
Film-coated tablets, 300 mg, per os, once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Patients With Negative HDV RNA by PCRTime frame: 72 weeks
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
State Budgetary educational institution of higher professional education "South Ural State Medical University" Ministry of healthcare
Chelyabinsk, Russia
State Budgetary Institution of healthcare "Specialized Clinical Infectious Diseases Hospital" Ministry of Health
Krasnodar, Russia
Moscow Regional Research and Clinical Institute
Moscow, Russia
Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance
Moscow, Russia
LLC "Clinic of Modern Medicine"
Moscow, Russia
Medical Company "Gepatolog" LLC
Samara, Russia
State Budgetary Institution of healthcare 'Stavropol regional clinical hospital'
Stavropol, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.